Back to PTCT
GOLDMAN SACHS GROUP INC → PTCT
GOLDMAN SACHS GROUP INC PTCT Position History
PTC Therapeutics, Inc. • Healthcare
Quarters held
20
Latest value
$677K
Q3 2026
Peak value
$60.9M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $26.4M |
| Q2 2025 | $11M |
| Q2 2025 | $494K |
| Q3 2025 | $43.3M |
| Q3 2025 | $10.5M |
| Q4 2025 | $214K |
| Q4 2025 | $18.8M |
| Q4 2025 | $58.7M |
| Q4 2025 | $58.7M |
| Q4 2025 | $18.8M |
| Q4 2025 | $214K |
| Q1 2026 | $40.1M |
| Q1 2026 | $16.3M |
| Q2 2026 | $34.2M |
| Q2 2026 | $16M |
| Q2 2026 | $314K |
| Q3 2026 | $43.3M |
| Q3 2026 | $60.9M |
| Q3 2026 | $342K |
| Q3 2026 | $677K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $677K | 10.4K | — | — |
| Q3 2026 | $342K | 5.3K | — | — |
| Q3 2026 | $60.9M | 940.6K | — | — |
| Q3 2026 | $43.3M | 668.1K | — | — |
| Q2 2026 | $314K | 3.8K | — | — |
| Q2 2026 | $16M | 195.7K | — | — |
| Q2 2026 | $34.2M | 418.7K | — | — |
| Q1 2026 | $16.3M | 239.7K | — | — |
| Q1 2026 | $40.1M | 587.9K | — | — |
| Q4 2025 | $214K | 2.8K | — | — |
| Q4 2025 | $18.8M | 247.2K | — | — |
| Q4 2025 | $58.7M | 773.0K | — | — |
| Q4 2025 | $58.7M | 773.0K | — | — |
| Q4 2025 | $18.8M | 247.2K | — | — |
| Q4 2025 | $214K | 2.8K | — | — |
| Q3 2025 | $10.5M | 171.0K | — | — |
| Q3 2025 | $43.3M | 705.5K | — | — |
| Q2 2025 | $494K | 10.1K | — | — |
| Q2 2025 | $11M | 225.8K | — | — |
| Q2 2025 | $26.4M | 539.9K | — | — |
Other funds holding PTCT
$784.3M
$683M
$631.9M
$628.6M
$615.3M
$588.4M
$527.8M
$479.2M